Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT
Lyell Immunopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 98.8M | 120.33M | 105.6M | 100.3M | 133.42M | 125.65M | 145.65M | 286.21M | 224.37M | 109.43M | 123.55M | 116.31M | 205.74M | 222.6M | 293.83M | 393.5M | 564.44M | 244.37M |
Short-Term Investments | 177.99M | 180.85M | 264.93M | 340.25M | 357.69M | 400.65M | 400.58M | 289.22M | 371.38M | 503.34M | 516.6M | 531.82M | 449.82M | 391.32M | 320.97M | 225.42M | 260.08M | 360.56M |
Long-Term Investments | 19M | 47.95M | 32.01M | 39.11M | 19.29M | 19.29M | 48.51M | 54.73M | 68.95M | 90.18M | 115.04M | 144.52M | 178.44M | 271.12M | 330.53M | 400.96M | 233.71M | 118.65M |
Other Long-Term Assets | 24.17M | 4.91M | 6.31M | 5.35M | 4.24M | 4.24M | 4.52M | 4.71M | 4.8M | 4.88M | 4.96M | 3.19M | 3.99M | 3.85M | 3.95M | 3.13M | 3.26M | 3.93M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.42M | 8M | 9.07M | 9.5M | 8.71M | 7.87M | 8.46M | 11.42M | 10.66M | 11.63M | 11.14M | 11.61M | 11.21M | 11.79M | 11.49M | 12.23M | 10.32M | 4.8M |
Total Current Assets | 282.21M | 309.18M | 379.59M | 450.05M | 499.82M | 534.16M | 554.69M | 586.85M | 606.41M | 624.4M | 651.29M | 659.75M | 666.78M | 625.71M | 626.29M | 631.15M | 834.84M | 609.74M |
Property-Plant & Equipment | 60.07M | 67.77M | 72.94M | 124.71M | 130.79M | 136.53M | 142.32M | 148.7M | 155.19M | 160.99M | 166.26M | 169.81M | 172.47M | 171.43M | 166.64M | 163.09M | 158.06M | 144.87M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 103.24M | 120.62M | 111.27M | 169.17M | 154.32M | 160.06M | 195.34M | 208.13M | 228.94M | 256.05M | 286.27M | 317.52M | 354.9M | 446.4M | 501.12M | 567.19M | 395.03M | 267.45M |
Total Assets | 385.45M | 429.8M | 490.86M | 619.22M | 654.14M | 694.22M | 750.03M | 794.99M | 835.35M | 880.45M | 937.56M | 977.27M | 1.02B | 1.07B | 1.13B | 1.2B | 1.23B | 877.19M |
Account Payables | 3.38M | 3.73M | 5.37M | 3.6M | 4.2M | 4.89M | 4.82M | 4.37M | 5.8M | 5.73M | 3.92M | 4.79M | 4.25M | 6.51M | 3.21M | 3.53M | 4.86M | 7.12M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 20.36M | -6.06M | -5.85M | -4.81M | 21.87M | 11.19M | 15.43M | 6.22M | 4.99M | 5.58M | 8.23M | 7.92M |
Short-Term Debt | n/a | 8.24M | 7.97M | 7.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 36.9M | -8.24M | 22.34M | -6.23M | 1.01M | 2.54M | 8.79M | 1.05M | 3.75M | 2.65M | 13.13M | 11.66M | 9.22M | 5.63M | 20.08M | 25.12M | 25.01M | 15.74M |
Total Current Liabilities | 36.9M | 41.28M | 53.79M | 33.51M | 30.88M | 32.35M | 34.52M | 35.06M | 34.39M | 30.8M | 37.03M | 51.22M | 50.29M | 41.05M | 46.74M | 59.28M | 63.66M | 56.81M |
Long-Term Debt | 46.6M | n/a | n/a | n/a | 53.32M | 55.16M | n/a | 58.58M | 60.22M | 61.83M | 63.17M | n/a | 66.07M | 67.47M | 66.65M | 65.68M | 61.47M | n/a |
Other Long-Term Liabilities | 3.03M | 3.14M | 3.25M | 3.56M | -49.88M | -51.61M | 3.66M | -54.8M | -56.33M | -57.83M | -59.05M | 4.23M | -61.73M | -63.02M | -62.08M | -60.67M | -60.57M | 893K |
Total Long-Term Liabilities | 49.63M | 51.99M | 54.25M | 55.01M | 56.76M | 58.71M | 60.56M | 62.35M | 64.11M | 65.83M | 67.28M | 106.03M | 103.34M | 149.8M | 150.88M | 152.58M | 144.25M | 143.46M |
Total Liabilities | 86.53M | 93.28M | 108.03M | 88.52M | 87.64M | 91.06M | 95.08M | 97.42M | 98.5M | 96.62M | 104.31M | 157.24M | 153.63M | 190.85M | 197.62M | 211.86M | 207.91M | 200.27M |
Total Debt | 46.6M | 48.85M | 58.97M | 51.44M | 60.22M | 61.83M | 63.17M | 58.58M | 60.22M | 61.83M | 67.7M | 64.64M | 66.07M | 67.47M | 67.82M | 65.68M | 61.47M | 57.76M |
Common Stock | 1K | 30K | 29K | 26K | 26K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 24K | 24K | 24K | 2K |
Retained Earnings | -1.44B | -1.4B | -1.35B | -1.15B | -1.11B | -1.06B | -1B | -949.18M | -898.33M | -834.44M | -767.48M | -759.08M | -688.83M | -652.51M | -584.36M | -500.66M | -451.78M | -389.19M |
Comprehensive Income | 57K | 158K | 291K | 760K | -397K | -404K | -94K | -1.18M | -2.38M | -3.88M | -7.6M | -10M | -8.35M | -6.6M | -1.62M | -65K | 73K | 163K |
Shareholders Equity | 298.92M | 336.52M | 382.82M | 530.7M | 566.5M | 603.16M | 654.95M | 697.57M | 736.86M | 783.83M | 833.25M | 820.03M | 868.04M | 881.25M | 929.79M | 986.47M | 1.02B | 676.92M |
Total Investments | 196.99M | 228.8M | 296.94M | 379.36M | 376.98M | 419.94M | 449.08M | 321.22M | 403.38M | 538.27M | 631.64M | 676.34M | 628.26M | 662.43M | 651.5M | 626.38M | 493.79M | 479.21M |